Extracorporeal Photopheresis With Low-Dose Immunosuppression in High-Risk Heart Transplant Patients-A Pilot Study.
Transplant International. 2022; 35:10320.
Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients.
Transfusion Medicine & Hemotherapy. 2020 Jun; 47(3):205-213.
A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Journal of Heart & Lung Transplantation. 2012 Sep; 31(9):950-7.
Renal allograft rejection controlled by photopheresis.
Lancet. 1995 Aug 19;346(8973):506. doi: 10.1016/s0140-6736(95)91355-6.
